Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

393
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
393
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

262
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
262
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A clustering-based trajectory analytics of functional loss and recovery among older adults.

PloS one·2026
Same author

Medication refill patterns and mortality in U.S. adults aged 85+: a retrospective Medicare cohort study.

The Gerontologist·2026
Same author

Responsible AI for Predicting Delayed Hospital Discharge Among Older Adults: Development and Evaluation Study for Balancing Accuracy, Equity, and Explainability.

JMIR medical informatics·2026
Same author

Did COVID-19 worsen the disparities among mental health patients at risk of exhibiting aggression in Ontario, Canada?

Health care management science·2026
Same author

Radiation Oncology Follow-Up of Prostate Cancer Survivors Following Completion of Radiotherapy: A Population-Based Study.

Current oncology (Toronto, Ont.)·2026
Same author

Foreword to the special issue: management science for pandemic prevention, preparedness, and response.

Health care management science·2025

相关实验视频

Updated: Sep 14, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

机器学习驱动的糖尿病护理使用预测-处方分析来实现个性化药物处方.

Manaf Zargoush1, Somayeh Ghazalbash2, Mahsa Madani Hosseini3

  • 1Health Policy and Management, DeGroote School of Business, McMaster University, Hamilton, ON, Canada. zargoush@mcmaster.ca.

Scientific reports
|July 23, 2025
PubMed
概括
此摘要是机器生成的。

机器学习 (ML) 可以通过一种新的临床决策支持系统 (CDSS) 来个性化2型糖尿病 (T2D) 治疗. 该框架优化了药物处方,尽管在复杂的病例中存在挑战,但显示出改善患者结果的希望.

关键词:
贝叶斯网络是一个贝叶斯网络.数据驱动优化的优化.机器学习是机器学习.个性化医疗是个性化的医疗.预测性-规范性分析.2 型糖尿病 2 型糖尿病

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K

相关实验视频

Last Updated: Sep 14, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K

科学领域:

  • 生物医学信息学 生物医学信息学
  • 人工智能在医学中的应用
  • 临床决策支持系统 临床决策支持系统

背景情况:

  • 2型糖尿病 (T2D) 患病率需要个性化治疗策略.
  • 机器学习 (ML) 为数据驱动的临床决策支持系统 (CDSS) 提供了潜力.
  • 目前的治疗方法需要对个体患者的个人资料进行改进.

研究的目的:

  • 开发一种使用ML进行增强T2D药物处方的新型预测-处方分析框架.
  • 创建一个数据驱动的CDSS以根据患者特定数据量身定制治疗策略.
  • 改善T2D管理的临床决策.

主要方法:

  • 使用了一个全面的电子健康记录数据集 (17,773名患者,12年).
  • 采用贝叶斯网络 (BN) 因为它们的双重预测和规范能力.
  • 应用基于规则和决策树的方法用于路径说明和可解释性.

主要成果:

  • ML表现出强大的预测性能 (精度:0.789,回忆:0.879,F1得分:0.831).
  • 在简单的场景中,ML建议与医生处方之间的一致性很高.
  • 随着处方复杂性的增加,对准度下降,这表明复杂的组合疗法存在挑战.

结论:

  • 开发了一个基于ML的CDSS框架,用于个性化T2D治疗.
  • 该框架显示了优化药物处方和改善患者治疗结果的前景.
  • 增强的CDSS对于复杂的治疗场景和医生合规性至关重要.